Zusammenfassung
OTC-Drugs (zum Beispiel Koffein, Ginkgo biloba), verschreibungspflichtige Medikamente (zum Beispiel Ritalin®, Attentin®, Adderall®) und illegale Drogen (zum Beispiel Speed, Crystal Meth) haben sehr unterschiedliche Einflüsse auf die geistige Leistungsfähigkeit. Tendenziell sind die Wirkungen von koffeinhaltigen Mitteln, Amphetaminen und Modafinil am ausgeprägtesten auf kognitive Domänen wie Vigilanz, Aufmerksamkeit, Konzentration und Gedächtnisleistungen. Dabei ist die Wirkung von Koffein geringer als die von Modafinil; Amphetamine sind am wirkungsvollsten. Die Wirkung der Neuroenhancer ist umso ausgeprägter, je beeinträchtigter – im Sinne von müde – die Einnehmenden im Vorfeld sind.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Referenzen und Literatur zum Weiterlesen
Allgemein
Benkert O & Hippius H (2019) Kompendium der Psychiatrischen Pharmakotherapie. (12. Aufl.) Springer-Verlag
de Jongh R et al (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neurosci Biobehav Rev 32:760–776
Franke AG et al (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch of Psychiatry Clin Neurosci 264(Suppl 1):83–90
Franke AG, Lieb K (2009) Missbrauch von Psychopharmaka zum „Cognitive Enhancement“. Mit Hirndoping zu intellektuellen Spitzenleistungen? InFo Neurologie Psychiatrie 11(7–8):42–51
Mehlman MJ (2004) Cognition-enhancing drugs. The Milbank Q 82(3):483–506
Koffein
Aggarwal R et al (2011) Effect of caffeine and taurine on simulated laparoscopy performed following sleep deprivation. Br J Surg 98(11):1666–1672
Alford C et al (2001) The effects of red bull energy drink on human performance and mood. Amino Acids 21:139–150
Fisone G et al (2004) Caffeine as a psychomotor stimulant: mechanism of action. Cell Mol Life Sci 61:857–872
Franke AG et al (2017) Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: a double-blind, randomised controlled trial. Eur Neuropsychopharmacol 27(3):248–260
Ishak WW et al (2012) Energy drinks: psychological effects and impact onwell-being and quality of life – a literature review. Innovations in Clin Neurosci 9:25–34
Ker K et al (2010) Caffeine for the prevention of injuries and errors in shift workers. Cochrane Database Syst Rev 5:CD008508
Killgore WD et al (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. J Sleep Res 17:309–321
Killgore WD et al (2009) Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep 32:205–216
Lin FJ et al (2010) Effect of taurine and caffeine on sleepwake activity in Drosophila melanogaster. Nat and Sci of Sleep 2:221–231
Miller KE (2008) Wired: energy drinks, jock identity, masculine norms, and risk taking. J Am Coll Health 56:481–489
Nehlig A et al (1992) Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev 17:139–170
Nestle M (2000) Soft drink „Pouring Rights“: marketing empty calories to children. Pub Health Rep 115(4):308–319
Preedy V (2015) Coffee in health and disease prevention, 1. Aufl. Elsevier, Amsterdam
Wesensten NJ (2014) Legitimacy of concerns about caffeine and energy drink consumption. Nutr Rev 72(Suppl. 1):78–86
Ginkgo biloba
Birks J, Grimley Evans J (2009) Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Systematic Reviews (1):CD003120
Burns NR et al (2006) Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults. Hum Psychopharmacol 21:27–37
Franke AG et al (2014) Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects. Eur Arch Psychiatry Clin Neurosci 264(Suppl 1):83–90
Franke AG, Lieb K (2009) Missbrauch von Psychopharmaka zum „Cognitive Enhancement“. Mit Hirndoping zu intellektuellen Spitzenleistungen? InFo Neurol Psychiatr 11(7–8):42–51
Kennedy DO et al (2002) Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults. Physiol Behav 75:739–751
Scholey AB (2002) Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol 17:35–44
Solomon PR et al (2002) Ginkgo for memory enhancement: a randomized controlled trial. J Am Med Assoc 288:835–840
Zhang HF et al (2016) An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia. Frontiers in Aging Neuroscience 8:276. https://doi.org/10.3389/fnagi.2016.00276 eCollection 2016
Antidementiva
de Jongh R et al. (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32:760–776
Franke AG, Lieb K (2009) Missbrauch von Psychopharmaka zum „Cognitive Enhancement“. Mit Hirndoping zu intellektuellen Spitzenleistungen? InFo Neurologie Psychiatrie 11(7–8):42–51
Franke AG et al. (2014) Substances used and prevalence rates of pharmacological Cognitive Enhancement among healthy subjects. European Archives of Psychiatry and Clinical Neurosciences 264 Suppl 1:83–90
Rammsayer TH (2001) Effects of pharmacologically induced changes in NMDA-receptor activity on long-term memory in humans. Learn & Mem 8:20–25
Rammsayer TH (2001) Effects of pharmacologically induced changes in NMDA receptor activity on human timing and sensorimotor performance. Brain Res 1073–1074:407–416
Modafinil
Bagot KS, Kaminer Y (2014) Efficacy of stimulants for cognitive enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction 109:547–557
Blaeser-Kiel G (2006) Schichtarbeiter-Syndrom: Es rächt sich, die innere Uhr zu ignorieren. Deutsches Ärzteblatt 103(7):A-424
Franke AG et al. (2017) Methylphenidate, modafinil, and caffeine for Cognitive Enhancement in chess: A double-blind, randomised controlled trial. European Neuropsychopharmacology 27(3):248–260
Jongh R de et al. (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32:760–776
Killgore WD (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. Journal of Sleep Research 17:309–321
Killgore WD (2009) Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep 32:205–216
Minzenberg MJ, Carter CS (2008) Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacol 33:1477–1502
Sugden C et al (2012) Effect of pharmacological enhancement on the cognitive and clinical psychomotor performance of sleep-deprived doctors: a randomized controlled trial. Ann Surg 255(2):222–227
Amphetamine
Bagot KS, Kaminer Y (2014) Efficacy of stimulants for Cognitive Enhancement in non-attention deficit hyperactivity disorder youth: a systematic review. Addiction 109:547–557
Baumgärtner M et al (2015) Crystal Meth: Produzenten, Dealer, Ermittler. Ch. Links Verlag GmbH, Berlin
Daumann J, Gouzoulis-Mayfrank E (2015) Amphetamine, Ecstasy und Designerdrogen. Kohlhammer, Stuttgart
de Jongh R et al. (2008) Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. Neuroscience & Biobehavioral Reviews 32:760–776
Franke AG et al. (2017) Methylphenidate, modafinil, and caffeine for Cognitive Enhancement in chess: A double-blind, randomised controlled trial. European Neuropsychopharmacology 27(3):248–260
Iversen L (2009) Speed, Ecstasy, Ritalin: Amphetamine-Theorie und Praxis. Huber, Bern
Killgore WD (2008) Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. Journal of Sleep Research 17:309–321
Killgore WD (2009) Sustaining executive functions during sleep deprivation: A comparison of caffeine, dextroamphetamine, and modafinil. Sleep 32:205–216
Neumann S et al (2016) Methamphetaminabhängigkeit in Deutschland. Eine selektive Übersicht über Epidemiologie, Phänomenologie und Therapie. Nervenheilkunde 35(11):742–747
Rasmussen N (2011) Medical science and the military: the Allies’ use of amphetamine during World War II. J Interdiscip Hist 42(2):205–233
Spencer RC et al (2012) Psychostimulants act within the prefrontal cortex to improve cognitive function. Biol Psychiatry 72:221–227
Wesensten NJ et al (2005) Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res 14(3):255–266
Antidepressiva
Elliott C (2003) Better than well: American medicine meets the American dream. WW Norton, New York
Hall W (2004) Feeling „better than well“. EMBO Rep 5(12):1105–1109
Harmer CJ et al (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacol 28:148–152
Harmer CJ et al (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256–1263
Knutson B et al (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155:333–339
Kramer P (1993) Listening to prozac. Penguin, New York
Tse W, Bond A (2002) Serotonergic intervention affects both social dominance and affiliative behavior. Psychopharmacolo 161:373–379
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Franke, A. (2019). Was wirkt und was nicht?. In: Hirndoping & Co.. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-58853-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-662-58853-6_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-58852-9
Online ISBN: 978-3-662-58853-6
eBook Packages: Medicine (German Language)